Related Experiment Video

Updated: May 6, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K

Angiosarcoma of the scalp successfully treated with pazopanib

Hajime Tomita1, Yuta Koike1, Misachi Asai1

  • 1Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Journal of the American Academy of Dermatology
|November 2, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

12.2K

Related Experiment Videos

Last Updated: May 6, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

29.3K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

12.2K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K

Articles linked to this work by shared authors, journal, and citation graph.

Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with Epcoritamab.

International journal of molecular sciences·2026

Immune Correlates of Denileukin Diftitox Treatment in TFH-Type Lymphoma.

Cancers·2026

Biomarker-based clustering identifies distinct pulmonary function trajectories in early systemic sclerosis.

Frontiers in immunology·2026

First Report of Laparoscopic Radical Nephroureterectomy Following Extraperitoneal Tubeless Umbilical Cutaneous Ureterostomy.

IJU case reports·2026

Synergistic effects of luspatercept and cyclosporine A in lower-risk myelodysplastic syndrome with red cell aplasia: Two case insights.

Leukemia research reports·2026

VEXAS Syndrome with Vibrio vulnificus Sepsis during Treatment with Tocilizumab.

Internal medicine (Tokyo, Japan)·2026

Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.

Journal of the American Academy of Dermatology·2026

The Effects of Tildrakizumab in the Epigenetic Aging Deviation of Psoriasis: A 52-Week Open-Label Study.

Journal of the American Academy of Dermatology·2026

Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy.

Annals of the New York Academy of Sciences·2026

Cardiopulmonary Exercise Testing Identifies Treatable ATTR Cardiac Amyloidosis: Beyond Natriuretic Peptides.

JACC. Case reports·2026

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease.

Frontiers in neurology·2026

Successful treatment of relapsed KMT2A rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report.

Therapeutic advances in hematology·2026

Exploring the cardioprotective role of metformin against isoproterenol-induced myocardial infarction using computational, cellular, and animal models.

3 Biotech·2026

Effect of rapid antiretroviral therapy initiation on loss to follow-up, virologic failure, and immunologic failure among people living with HIV under the treat-all policy in China: a retrospective cohort study (2016-2023).

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us